The
National Cancer Institute is funding two clinical trials to determine the effectiveness of using prolonged regulated
doses of thermal heat, in combination with chemotherapy, as a treatment for cancer. The hypothesis behind thermal
therapy hopes to prove that while heat is decreasing the pressure inside a tumor, more of the chemotherapy drugs can be
absorbed into the tumor. In addition, by inducing a fever in the patient, the natural infection-fighting defenses of the
body will stimulate the production of white blood cells. Patients currently enrolled in the two clinical trials are
cancer patients with advanced pancreatic cancer, melanoma, inoperable or metastatic neuroendocrine tumors, and cancers
of the gastric system, small bowel, lung, head and neck. Dr. Joan Bull, University of Texas Medical School at Houston
oncology professor and Center for Thermal Therapy Cancer
Treatment director, is leading the current trials.Note: The contents of this blog are for informational purposes only and should not be construed as medical advice or substitute for professional care. For medical emergencies, dial 911!
Thermal heat therapy as cancer treatment
The
National Cancer Institute is funding two clinical trials to determine the effectiveness of using prolonged regulated
doses of thermal heat, in combination with chemotherapy, as a treatment for cancer. The hypothesis behind thermal
therapy hopes to prove that while heat is decreasing the pressure inside a tumor, more of the chemotherapy drugs can be
absorbed into the tumor. In addition, by inducing a fever in the patient, the natural infection-fighting defenses of the
body will stimulate the production of white blood cells. Patients currently enrolled in the two clinical trials are
cancer patients with advanced pancreatic cancer, melanoma, inoperable or metastatic neuroendocrine tumors, and cancers
of the gastric system, small bowel, lung, head and neck. Dr. Joan Bull, University of Texas Medical School at Houston
oncology professor and Center for Thermal Therapy Cancer
Treatment director, is leading the current trials.
